Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
MNPR compared with PHVS: revenue, margins and what each company keeps, and the suppliers and customers both name
MNPR
Monopar Therapeutics
Change
Mkt cap
Revenue
Revenue
PHVS
Pharvaris N.V.
Change
Mkt cap
Revenue
Revenue
vs
Compare
MNPR
Monopar Therapeutics
vs
PHVS
Pharvaris N.V.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
MNPR
Report
implied
realized
× implied
Q2 FY26
—
▲
+0.38%
—
May 14 '26
—
▼
−0.73%
—
Q1 FY26
—
▼
−0.84%
—
Q3 FY25
—
▲
+5.36%
—
PHVS
No earnings history for PHVS.
= implied
MNPR realized, solid
PHVS realized, hatched
One scale, both sides: full bar = 6%
× = |realized| ÷ implied
Source: market data
MNPR
Monopar Therapeutics
Change
71.11
▲
+5.79%
· post 71.11
Mkt cap
$479.4M
PHVS
Pharvaris N.V.
Change
34.53
▲
+6.16%
· post 34.54
Closed
Nov 6 '26
Mkt cap
$2.2B
vs
Compare
Closed
Nov 6 '26
MNPR
Monopar Therapeutics
vs
PHVS
Pharvaris N.V.
71.11
▲
+5.79%
post 71.11
Price
34.53
▲
+6.16%
post 34.54
$479.4M
Mkt cap
$2.2B
Change
Change
MNPR
71.11
▲
+5.79%
vs
PHVS
34.53
▲
+6.16%
Closed
Nov 6 '26